Blog Comments

Kinetica Online is pleased to provide direct links to commentaries from our senior editor Dr. Steven Pelech has posted on other blogs sites. Most of these comments appear on the GenomeWeb Daily Scan website, which in turn highlight interesting blogs that have been posted at numerous sites in the blogosphere since the beginning of 2010. A wide variety of topical subjects are covered ranging from the latest scientific breakthroughs, research trends, politics and career advice. The original blogs and Dr. Pelech’s comments are summarized here under the title of the original blog. Should viewers wish to add to these discussions, they should add their comments at the original blog sites.

The views expressed by Dr. Pelech do not necessarily reflect those of the other management and staff at Kinexus Bioinformatics Corporation. However, we wish to encourage healthy debate that might spur improvements in how biomedical research is supported and conducted.

Battelle Report

Return on Investment

A new report from United for Medical Research and Battelle claimed that while the US government invested about $14.5 billion between 1988 and 2012 in the Human Genome Project, it has reaped $59 billion in tax revenue and $965 billion in economic impact. The report further suggests that the investment has lead to 53,000 genomics-related jobs and $293 billion in personal income. S. Pelech notes the timing of the release of the report with the reduction of NIH research funding through the sequestration, and challenges some of the conclusions of the study. He notes that there has been essentially no growth in employment in any of the various genomics sectors in the last 5 years. Read More...

A Good Return

In his recent State of the Union address, US President Barack Obama made mention of how for every dollar the US government invested to map the human genome, $140 was returned to the US economy. This was based on a 2011 report by the Battelle Technology Partnership Practice, which calculated the direct, indirect, and induced impacts of human genome sequencing on employment, personal income, output, and tax revenue. S. Pelech challenges the accuracy of these estimates and pointed out that private industry and non-HGP government- and charity-funded investigator-driven projects really made the major in-roads in the identification and characterization of most of the human genes that have been targeted by the pharmaceutical and biotech industry to date. He also takes issue with the claims of the actual direct economic and scientific benefits of the Human Genome Project. Read More...